Browse the full directors' dealings record of 华大基因, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €19bn. The latest transaction was reported on 22 September 2025 — Sale. Among the most active insiders: 汪建. The full history is accessible without an account.